Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy

References

• Caruso S, Malandrino C, Cicero C, et al. Quality of sexual life of women on oral contraceptive continued-regimen: pilot study. J Sex Med. 2013;10:460–466.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Romano M, et al. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. J Sex Med. 2011;8:2841–2850.
   PubMed Web of Science ®Google Scholar
• United Nations Department of Economic and Social Affairs Population Division [Internet]. [cited 2009 Aug 5]. World contraceptive use 2007. Available from: http://www.un.org/esa/population/publications/contraceptive2007/contraceptive2007.htm
   Google Scholar
• De Leo V, Musacchio MC, Cappelli V, et al. Hormonal contraceptives: pharmacology tailored to women's health. Hum Reprod Update. 2016;22:634–646.
   PubMed Web of Science ®Google Scholar
• Nelson DB, Zhao H, Corrado R, et al. Preventing unintended pregnancy among young sexually active women: recognizing the role of violence, self-esteem, and depressive symptoms on use of contraception. J Womens Health (Larchmt). 2017;26:352–360.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Selected practice recommendations for contraceptive use. 3rd ed. Geneva: World Health Organization; 2016.
   Google Scholar
• Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann. 2014;45:301–314.
   PubMed Web of Science ®Google Scholar
• Schreiber CA, Sober S, Ratcliffe S, et al. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84:230–233.
   PubMed Web of Science ®Google Scholar
• Boesen HC, Rørbye C, Nørgaard M, et al. Sexual behavior during the first eight weeks after legal termination of pregnancy. Acta Obstet Gynecol Scand. 2004;83:1189–1192.
   PubMed Web of Science ®Google Scholar
• Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206:37.e1–e6.
   PubMed Web of Science ®Google Scholar
• Rowlands S, Gemzell-Danielsson K. Postabortion contraception. Eur J Contracept Reprod Health Care. 2017;22:162–163.
   PubMed Web of Science ®Google Scholar
• Okusanya BO, Oduwole O, Effa EE. Immediate postabortal insertion of intrauterine devices. Cochr Database Syst Rev. 2014;7:CD001777.
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38:633–638.
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1159–1165.
   PubMed Web of Science ®Google Scholar
• Basson R, Leiblum S, Brotto L, et al. Revised definitions of women’s sexual dysfunction. J Sex Med. 2004;1:40–48.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Vaccaro P, et al. Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol. 2008;24:214–209.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rosen R, Leiblum S, et al. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–330.
   PubMed Web of Science ®Google Scholar
• Bastianelli C, Farris M, Benagiano G. Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contraception. 2011;84:402–408.
   PubMed Web of Science ®Google Scholar
• Skrzypulec V, Drosdzol A. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system-Mirena. Coll Antropol. 2008;32:1059–1068.
   PubMedGoogle Scholar
• Gorgen H, Api M, Akça A, et al. Use of the levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet. 2009;279:835–840.
   PubMed Web of Science ®Google Scholar
• Baldaszti E, Wimmer-Puchinger B, Löschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception. 2003;67:87–91.
   PubMed Web of Science ®Google Scholar
• Halmesmäki K, Hurskainen R, Teperi J, et al. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial. BJOG. 2007;114:563–568.
   PubMed Web of Science ®Google Scholar
• Enzlin P, Weyers S, Janssens D, et al. Sexual functioning in women using levonorgestrel -releasing intrauterine systems as compared to copper intrauterine devices. J Sex Med. 2012;9:1065–1073.
   PubMed Web of Science ®Google Scholar
• Neri M, Piras B, Paoletti AM, et al. Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women. Gynecol Endocrinol. 2017 [Dec 19; [1–4]. DOI: 10.1080/09513590.2017.1416465.
   Web of Science ®Google Scholar
• Hubacher D, Spector H, Monteith C, et al. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Am J Obstet Gynecol. 2017;216:101–109.
   PubMed Web of Science ®Google Scholar
• Tazegül Pekin A, Seçilmiş Kerimoğlu O, Kebapcılar AG, et al. Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study. Arch Gynecol Obstet. 2014;290:507–511.
   PubMed Web of Science ®Google Scholar
• Skovlund CW, Mørch LS, Kessing LV, et al. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73:1154–1162.
   PubMed Web of Science ®Google Scholar
• Andréen L, Nyberg S, Turkmen S, et al. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology. 2009;34:1121–1132.
   PubMed Web of Science ®Google Scholar
• Klaiber EL, Broverman DM, Vogel W, et al. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology. 1996;21:575–592.
   PubMed Web of Science ®Google Scholar
• Poromaa IS, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand. 2012;91:420–427.
   PubMed Web of Science ®Google Scholar
• Caruso S, Cianci S, Cariola M, et al. Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17β-Estradiol. J Womens Health (Larchmt). 2017;26:728–734.
   PubMed Web of Science ®Google Scholar
• Wellings K, Brima N, Sadler K, et al. Stopping and switching contraceptive methods: findings from Contessa, a prospective longitudinal study of women of reproductive age in England. Contraception. 2015;91:57–66.
   PubMed Web of Science ®Google Scholar
• Caruso S, Rugolo S, Agnello C, et al. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate. J Sex Med. 2009;6:3376–3384.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Abalos V, Apter D, et al. Targeting factors for change: contraceptive counselling and care of female adolescents. Eur J Contracept Reprod Health Care. 2016;21:417–430.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Malandrino C, et al. Do hormones influence women’s sex? Sexual activity over the menstrual cycle. J Sex Med. 2014;11:211–221.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Kopp HK. Post abortion contraception. Womens Health (Lond). 2015;11:779–784.
   PubMed Web of Science ®Google Scholar
• Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group. Committee opinion no. 642: increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2015;126:e44–e48.
   PubMed Web of Science ®Google Scholar
• Ames CM, Norman WV. Preventing repeat abortion in Canada: is the immediate insertion of intrauterine devices postabortion a cost-effective option associated with fewer repeat abortions? Contraception. 2012;85:51–55.
   PubMed Web of Science ®Google Scholar
• Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007.
   PubMed Web of Science ®Google Scholar
• Curtis KM, Peipert JF. Long-acting reversible contraception. N Engl J Med. 2017;376:461–468.
   PubMed Web of Science ®Google Scholar
• Birgisson NE, Zhao Q, Secura GM, et al. Preventing unintended pregnancy: the Contraceptive CHOICE Project in review. J Womens Health (Larchmt). 2015;24:349–353.
   PubMed Web of Science ®Google Scholar
• Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371:1316–1323.
   PubMed Web of Science ®Google Scholar
• Harper CC, Henderson JT, Raine TR, et al. Evidence-based IUD practice: family physicians and obstetrician-gynecologists. Fam Med. 2012;44:637–645.
   PubMed Web of Science ®Google Scholar
• Beeson T, Wood S, Bruen B, et al. Accessibility of long-acting reversible contraceptives (LARCs) in federally qualified health centers (FQHCs). Contraception. 2014;89:91–96.
   PubMed Web of Science ®Google Scholar